Patients with the clinical picture of COVID-19-associated TTP were characterized by lower platelet counts (median platelets count in patients with TTP was 14, range 5–100, compared to 36, range 6–157, in aHUS) and very low ADAMTS13 activity (<10% in all cases). This evidence concerns the gene ADAMTS13 and COVID-19.